CD36 mutant gene and methods for diagnosing diseases caused by abnormal lipid metabolism and diagnostic kits therefor
AssigneeWakunaga Phaemaceutical Co., Ltd.
InventorsTakanori Oka, Akio Yamane, Takao Tanaka
Life of this patent
Estimating the term…
Abstract
The present invention provides CD36 mutant gene and methods and kits for diagnosing diseases caused by a lipid metabolism abnormality.
Claims14
A CD36 mutant gene comprising a nucleotide sequence selected from the sequences of SEQ ID NO:
- 1 through SEQ ID NO:
- 8.
A nucleotide sequence fragment comprising a nucleotide sequence selected from the sequences of SEQ ID NO:1 through SEQ ID NO:8, or a mutated portion thereof.
A primer which detects a mutation of the CD 36 gene comprising a nucleotide fragment consisting of at least 12 consecutive nucleotides of the CD36 mutant gene nucleotide sequence or a full complement thereof.
Dependencies are inferred from the claim text.